Jasmin Tiro to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Jasmin Tiro has written about Carcinoma, Hepatocellular.
Connection Strength
3.380
-
Novel Application of Predictive Modeling: A Tailored Approach to Promoting HCC Surveillance in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2022 08; 20(8):1795-1802.e2.
Score: 0.575
-
Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System. J Clin Gastroenterol. 2017 Aug; 51(7):650-655.
Score: 0.449
-
Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prev Res (Phila). 2012 Sep; 5(9):1124-30.
Score: 0.317
-
Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review. J Gen Intern Med. 2012 Jul; 27(7):861-7.
Score: 0.305
-
Financial Burden of Hepatocellular Carcinoma Screening in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2024 Apr; 22(4):760-767.e1.
Score: 0.170
-
Hepatocellular carcinoma surveillance may be associated with potential psychological harms in patients with cirrhosis. Hepatology. 2024 Jan 01; 79(1):107-117.
Score: 0.169
-
Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance. Clin Gastroenterol Hepatol. 2022 12; 20(12):2818-2825.e1.
Score: 0.152
-
Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2021 05; 19(5):987-995.e1.
Score: 0.137
-
Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma. Aliment Pharmacol Ther. 2020 08; 52(4):701-709.
Score: 0.137
-
Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial. Hepatology. 2019 01; 69(1):121-130.
Score: 0.123
-
An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis. Hepatology. 2017 04; 65(4):1196-1205.
Score: 0.108
-
Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma. Gastroenterology. 2017 02; 152(3):608-615.e4.
Score: 0.107
-
Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis. Hepatology. 2017 03; 65(3):875-884.
Score: 0.106
-
Role functioning is associated with survival in patients with hepatocellular carcinoma. Qual Life Res. 2015 Jul; 24(7):1669-75.
Score: 0.093
-
Racial, social, and clinical determinants of hepatocellular carcinoma surveillance. Am J Med. 2015 Jan; 128(1):90.e1-7.
Score: 0.091
-
Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):791-8.e1.
Score: 0.091
-
Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma. J Natl Compr Canc Netw. 2013 Sep 01; 11(9):1101-8.
Score: 0.086
-
Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail? Am J Gastroenterol. 2013 Mar; 108(3):425-32.
Score: 0.082
-
Improving hepatocellular carcinoma screening: applying lessons from colorectal cancer screening. Clin Gastroenterol Hepatol. 2013 May; 11(5):472-7.
Score: 0.081